🇺🇸 Nopan in United States
16 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 16
Most-reported reactions
- Agitation — 2 reports (12.5%)
- Dysstasia — 2 reports (12.5%)
- Logorrhoea — 2 reports (12.5%)
- Methaemoglobinaemia — 2 reports (12.5%)
- Muscular Weakness — 2 reports (12.5%)
- Skin Discolouration — 2 reports (12.5%)
- Somnolence — 2 reports (12.5%)
- Tachyphrenia — 2 reports (12.5%)
Other Other approved in United States
Frequently asked questions
Is Nopan approved in United States?
Nopan does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Nopan in United States?
Prof. Yoram Yovell is the originator. The local marketing authorisation holder may differ — check the official source linked above.